• Je něco špatně v tomto záznamu ?

Reactive hyperaemia index as a marker of endothelial dysfunction in children with Crohn's disease is significantly lower than healthy controls

J. Petr, H. Michal, S. Jan, T. Ladislav, K. Jiri, S. Josef,

. 2014 ; 103 (2) : e55-60.

Jazyk angličtina Země Norsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14074594

AIM: Patients with inflammatory bowel disease (IBD) are prone to cardiovascular disorders, although there is little research to support this assertion, and other data are controversial in children. We aimed to determine the extent of premature atherosclerosis in Crohn's disease (CD) by measuring reactive hyperaemia index (RHI) as a functional marker of endothelial dysfunction (ED). METHODS: Twenty-one patients with CD and twelve healthy matched subjects were enrolled in the study. Diagnosis was based on the standard clinical, endoscopic and histological criteria, including the Paediatric Crohn's disease Activity Index. ED was assessed using the plethysmographic RHI, combined with specific biochemical markers of ED. RESULT: RHI values were significantly lower in the patients with CD than the controls (p < 0.05). E-selectin (p < 0.05), asymmetric dimethylarginine (p < 0.01) and high-sensitive CRP (p < 0.05), but not vascular cells adhesive molecule-1 values, were significantly increased in the CD subjects compared with the control group. CONCLUSION: Significantly decreased RHI and elevated plasma levels of specific biochemical parameters seems to be related to systemic inflammation and ED in children with CD. Our results support the hypothesis regarding RHI and ED in paediatric CD. This combined method assessment might be a useful tool for detection of ED and stratification of cardiovascular risk in patients with CD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074594
003      
CZ-PrNML
005      
20141007095901.0
007      
ta
008      
141006s2014 no f 000 0|eng||
009      
AR
024    7_
$a 10.1111/apa.12467 $2 doi
035    __
$a (PubMed)24127842
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a no
100    1_
$a Petr, Jehlicka $u Department of Paediatrics, Faculty Hospital, Pilsen, Czech Republic; Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic.
245    10
$a Reactive hyperaemia index as a marker of endothelial dysfunction in children with Crohn's disease is significantly lower than healthy controls / $c J. Petr, H. Michal, S. Jan, T. Ladislav, K. Jiri, S. Josef,
520    9_
$a AIM: Patients with inflammatory bowel disease (IBD) are prone to cardiovascular disorders, although there is little research to support this assertion, and other data are controversial in children. We aimed to determine the extent of premature atherosclerosis in Crohn's disease (CD) by measuring reactive hyperaemia index (RHI) as a functional marker of endothelial dysfunction (ED). METHODS: Twenty-one patients with CD and twelve healthy matched subjects were enrolled in the study. Diagnosis was based on the standard clinical, endoscopic and histological criteria, including the Paediatric Crohn's disease Activity Index. ED was assessed using the plethysmographic RHI, combined with specific biochemical markers of ED. RESULT: RHI values were significantly lower in the patients with CD than the controls (p < 0.05). E-selectin (p < 0.05), asymmetric dimethylarginine (p < 0.01) and high-sensitive CRP (p < 0.05), but not vascular cells adhesive molecule-1 values, were significantly increased in the CD subjects compared with the control group. CONCLUSION: Significantly decreased RHI and elevated plasma levels of specific biochemical parameters seems to be related to systemic inflammation and ED in children with CD. Our results support the hypothesis regarding RHI and ED in paediatric CD. This combined method assessment might be a useful tool for detection of ED and stratification of cardiovascular risk in patients with CD.
650    _2
$a mladiství $7 D000293
650    _2
$a ateroskleróza $7 D050197
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a Crohnova nemoc $x krev $x komplikace $x patofyziologie $7 D003424
650    _2
$a cévní endotel $x patofyziologie $7 D004730
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hyperemie $x komplikace $x patofyziologie $7 D006940
650    _2
$a mužské pohlaví $7 D008297
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Michal, Huml
700    1_
$a Jan, Schwarz
700    1_
$a Ladislav, Trefil
700    1_
$a Jiri, Kobr
700    1_
$a Josef, Sykora
773    0_
$w MED00009036 $t Acta paediatrica (Oslo, Norway : 1992) $x 1651-2227 $g Roč. 103, č. 2 (2014), s. e55-60
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24127842 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20141007100339 $b ABA008
999    __
$a ok $b bmc $g 1042477 $s 873506
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 103 $c 2 $d e55-60 $i 1651-2227 $m Acta paediatrica (Oslo) $n Acta Paediatr $x MED00009036
LZP    __
$a Pubmed-20141006

Najít záznam

Citační ukazatele

Možnosti archivace